Keywords:
parkinson's disease (pd), immunosuppression, stem cells, da neurons, transplantation, sequencing.References
Rachel Hills, Jim A. Mossman, Andres M. Bratt–Leal, Ha Tran, Roy M. Williams, David G. Stouffer, Irina V. Sokolova, Pietro P. Sanna, Jeanne F. Loring, and Mariah J. Lelos.Neurite Outgrowth and Gene Expression Profile Correlate with Efficacy of Human Induced Pluripotent Stem Cell–Derived Dopamine Neuron Grafts.Stem Cells and Development. Jul 2023.387–397.
Barker R.A. and Consortium T. (2019). Development of stem cell–based dopamine cell replacement studies for Parkinson's disease. Nat. Honey. 25, 1045–1053. doi: 10.1038/s41591–019–0507–2
Cardozo T., Adler A.F., Mattsson B., Hoban D.B., Nolbrant S., Wahlestedt J.N. et al. (2018). Goal–directed forebrain projections and corresponding synaptic dopamine neurons. Neurol. 526, 2133–2146. doi: 10.1002/cne.24500
Fan, Y., Winanto, & Ng, X. Y. (2020). Replacing what is lost: a new era of stem cell therapy for Parkinson's disease. Neurodegener. 9:2. doi: 10.1186 /s40035–019–0180–x
Goggi JL, Qiu L, Liao MK, Khanapur S, Jiang L, Bhuminathan R, et al (2020). Neuroimaging of the dopamine transporter accurately assesses dopamine neuron maturation in a preclinical model of Parkinson's disease. Stem Cells Res. There. 11:347. doi: 10.1186/s13287–020–01868–4
Lang, K., Campbell, K. R., Ryan, B. J., Carling, P., Attar, M., Vowles, J., et al. (2019). Single–cell sequencing of ipsc–dopamine neurons reconstruct disease progression and identifies Hdac4 as a regulator of Parkinson cell phenotypes. 24, 93.e6–106.e6. doi: 10.1016/j.stem.2018.10.023
Malloy K. E., Lee J., Chowdhury G. R., Torres A., Gupta S., Kantorak K. et al. (2017). Magnetic resonance imaging–guided delivery of neural stem cells into the basal ganglia of non–human primates reveals a pulsatile mode of cell dispersion. Per. Honey. 6, 877–885. doi: 10.5966/sctm.2016–0269
Stem cell therapy for central nervous system disorders: Metabolic interactions between transplanted cells and local microenvironments
https://www.sciencedirect.com/science/ article/pii/S0969996122002340
M. Knobloch, et al. A fatty acid oxidation–dependent metabolic shift regulates adult neural stem cell activity https://www.cell.com/cell–reports/pdf/S2211–1247(17)31136–1.pdf
Hung Nguyen, et al. Stem cell therapy for neurological disorders: A focus on aging https:// www.sciencedirect.com/science/article/abs/pii/ S0969996118305746 // doi.org/10.1016/ j.nbd.20 18.09.011
Ottoboni, L.,et al Neural stem cell plasticity: Advantages in therapy for the injured central nervous system (Review) https://www.scopus.com /record/display.uri?eid=2–s2.0–85026813179&ori-gin=inward&txGid=dc57c08d17248006f81633850 f2ec42b
Elliot G. Neal et all, An update on intracerebral stem cell grafts https://doi.org/10.1080/147 37175.2018.1491309
Positive results announced from early-stage stem cell therapy trial https://www.parkinsons.org.uk/news/positive–results–announced–early–stage–stem–cell–therapy–trial
Jasmina Isakovic et al, Mesenchymal stem cell therapy for neurological disorders: Front. Bioeng.Biotechnol.,28February2023 https://www.frontiersin.org/articles/10.3389/fbioe.2023.1139359/ full#:~:text=https%3A//doi.org/10.3389/fbioe.2023.1139359
Michael J. Fox Foundation Stem Cells for Parkinson’s: Therapy and Tools for a Neurological Disorder https://www.closerlookatstemcells.org / 2019/04/01/stem–cells–for–parkinsons–therapy–and–tools–for–a–neurological–disorder/
Stem Cell–Based Therapies to Treat Parkinson’s https://www.parkinson.ca/stem–cell–bas-ed–therapies–to–treat–parkinsons/
Tae Wan Kim,So Yeon Koo,Lorenz Studer.Pluripotent Stem Cell Therapies for Parkinson Disease: Present Challenges and Future Opportunitieshttps://www.frontiersin.org/journals/cell–and–developmental–biology/articles/10.3389/fcell.202 0.00729/full.
Park, TY., Jeon, J., Lee, N. et al. Co–transplantation of autologous Treg cells in a cell therapy for Parkinson’s disease https://www.nature.com/ articles/s41586–023–06300–4
Agnete Kirkeby, Jenny Nelander, Deirdre B. Hoban. Gesine Paul, Roger A. Barker, Malin Parmar.Preclinical quality, safety, and efficacy of a human embryonic stem cell–derived product for the treatment of Parkinson’s disease, STEM–PD. https://www.cell.com/cell–stem–cell/fulltext/S19 34–5909(23)00321–1?_returnURL=https%3A%2F %2Flinkinghub.elsevier.com%2Fretrieve%2Fpii% 2FS1934590923003211%3Fshowall%3Dtrue
Stem cell therapy success in early trial to treat Parkinson's disease https://www.progress. org.uk/stem–cell–therapy–success–in–early–trial–to–treat–parkinsons–disease/